Old Web
English
Sign In
Acemap
>
authorDetail
>
Vano Yann-Alexandre
Vano Yann-Alexandre
Medicine
Pathology
Oncology
Internal medicine
Renal cell carcinoma
4
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Retrospective evaluation of tyrosine kinase inhibitor (TKI)-everolimus (eve) and/or TKI-eve-TKI sequences in metastatic renal cell carcinoma (mRCC): A French survey—The sector study.
2014
Journal of Clinical Oncology
S. Oudard
Florence Joly
Lionnel Geoffrois
Brigitte Laguerre
Nadine Houede
Philippe Barthélémy
Marine Gross-Goupil
Vano Yann-Alexandre
Olivier Lucidarme
François Bidault
Nadia Kelkouli
Bernard Escudier
Show All
Source
Cite
Save
Citations (1)
Prognostic impact of baseline serum C-reactive protein in metastatic renal cell carcinoma treated with sunitinib.
2013
Journal of Clinical Oncology
Vano Yann-Alexandre
Benoit Beuselinck
Pascal Wolter
Corine Teghom
Debruyne Philip
Alexandra Karadimou
Evelyne Lerut
Paridaens Robert
Patrick Schöffski
S. Oudard
Show All
Source
Cite
Save
Citations (3)
Impact of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2 overexpressing breast carcinomas.
2012
Journal of Clinical Oncology
Jean-Sebastien Frenel
Manuel Jorge Rodrigues
Julien Péron
Vano Yann-Alexandre
Johanna Wassermann
Marc Debled
François Picaud
Laurence Albiges
Anne Vincent-Salomon
Paul Cottu
Show All
Source
Cite
Save
Citations (2)
1